Compare, Analyse IPCA Labs with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-19
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,042369-   
Low Rs590266-   
Sales per share (Unadj.) Rs298.6109.8-  
Earnings per share (Unadj.) Rs35.0-27.7-  
Cash flow per share (Unadj.) Rs49.4-22.9-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.186.2-  
Shares outstanding (eoy) m126.35168.78-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.72.9 94.4%   
Avg P/E ratio x23.3-11.5 -203.1%  
P/CF ratio (eoy) x16.5-13.9 -119.1%  
Price / Book Value ratio x3.33.7 89.6%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,10853,607 192.3%   
No. of employees `00013.44.3 313.1%   
Total wages/salary Rs m7,8743,364 234.0%   
Avg. sales/employee Rs Th2,807.04,315.8 65.0%   
Avg. wages/employee Rs Th585.8783.7 74.7%   
Avg. net profit/employee Rs Th329.0-1,087.5 -30.3%   
INCOME DATA
Net Sales Rs m37,73218,528 203.7%  
Other income Rs m577130 444.6%   
Total revenues Rs m38,30918,657 205.3%   
Gross profit Rs m6,901-3,211 -214.9%  
Depreciation Rs m1,824800 228.1%   
Interest Rs m189502 37.6%   
Profit before tax Rs m5,465-4,382 -124.7%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,042274 380.7%   
Profit after tax Rs m4,422-4,669 -94.7%  
Gross profit margin %18.3-17.3 -105.5%  
Effective tax rate %19.1-6.2 -305.3%   
Net profit margin %11.7-25.2 -46.5%  
BALANCE SHEET DATA
Current assets Rs m23,77813,570 175.2%   
Current liabilities Rs m10,9757,635 143.7%   
Net working cap to sales %33.932.0 105.9%  
Current ratio x2.21.8 121.9%  
Inventory Days Days104111 93.5%  
Debtors Days Days66124 53.2%  
Net fixed assets Rs m20,3687,910 257.5%   
Share capital Rs m25386 293.8%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,22414,542 214.7%   
Long term debt Rs m1,4095,110 27.6%   
Total assets Rs m45,50727,471 165.7%  
Interest coverage x30.0-7.7 -387.5%   
Debt to equity ratio x00.4 12.8%  
Sales to assets ratio x0.80.7 122.9%   
Return on assets %10.1-15.2 -66.8%  
Return on equity %14.2-32.1 -44.1%  
Return on capital %17.3-19.8 -87.5%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,9231,581 311.3%  
From Investments Rs m-1,563-486 321.9%  
From Financial Activity Rs m-1,8324,638 -39.5%  
Net Cashflow Rs m1,5285,734 26.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.09 Rs / ZAR

Compare IPCA LABS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: SANOFI INDIA  DISHMAN PHARMA  ALEMBIC  FULFORD INDIA  NEULAND LABS  



Today's Market

RBI's Relief Measures Amid Covid, 5G Trials by Mobile Operators, and Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed positive trading activity throughout the day yesterday and ended higher.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider (Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Learn: How to Potentially Accumulate Rs 7 Crore in Wealth Over the Long-term
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


May 5, 2021 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - BIOCON COMPARISON

COMPARE IPCA LABS WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS